Lipid Identification of Biomarkers in Esophageal Squamous Cell Carcinoma by Lipidomic Analysis

References

• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi: 10.3322/caac.21492.
   PubMed Web of Science ®Google Scholar
• Hou H, Meng Z, Zhao X, Ding G, Sun M, Wang W, Wang Y. Survival of esophageal cancer in China: a pooled analysis on hospital-based studies from 2000 to 2018. Front Oncol. 2019;9:548. doi: 10.3389/fonc.2019.00548.
   PubMed Web of Science ®Google Scholar
• Napier KJ, Scheerer M, Misra S. Esophageal cancer: a review of epidemiology, pathogenesis, staging workup and treatment modalities. World J Gastrointest Oncol. 2014;6(5):112–20. doi: 10.4251/wjgo.v6.i5.112.
   PubMed Web of Science ®Google Scholar
• Mannath J, Ragunath K. Role of endoscopy in early oesophageal cancer. Nat Rev Gastroenterol Hepatol. 2016;13(12):720–30. doi: 10.1038/nrgastro.2016.148.
   PubMed Web of Science ®Google Scholar
• Chen XX, Zhong Q, Liu Y, Yan SM, Chen ZH, Jin SZ, Xia TL, Li RY, Zhou AJ, Su Z, et al. Genomic comparison of esophageal squamous cell carcinoma and its precursor lesions by multi-region whole-exome sequencing. Nat Commun. 2017;8(1):524. doi: 10.1038/s41467-017-00650-0.
   PubMed Web of Science ®Google Scholar
• Li F, Li X, Guo C, Xu R, Li F, Pan Y, Liu M, Liu Z, Shi C, Wang H, et al. Estimation of cost for endoscopic screening for esophageal cancer in a high-risk population in Rural China: results from a population-level randomized controlled trial. Pharmacoeconomics. 2019;37(6):819–27. doi: 10.1007/s40273-019-00766-9.
   PubMed Web of Science ®Google Scholar
• Yang Y, Huang X, Zhou L, Deng T, Ning T, Liu R, Zhang L, Bai M, Zhang H, Li H, et al. Clinical use of tumor biomarkers in prediction for prognosis and chemotherapeutic effect in esophageal squamous cell carcinoma. BMC Cancer. 2019;19(1):526. doi: 10.1186/s12885-019-5755-5.
   PubMedGoogle Scholar
• Armitage EG, Southam AD. Monitoring cancer prognosis, diagnosis and treatment efficacy using metabolomics and lipidomics. Metabolomics. 2016;12(9):146. doi: 10.1007/s11306-016-1093-7.
   PubMed Web of Science ®Google Scholar
• Nguyen A, Rudge SA, Zhang Q, Wakelam MJ. Using lipidomics analysis to determine signalling and metabolic changes in cells. Curr Opin Biotechnol. 2017;43:96–103. doi: 10.1016/j.copbio.2016.10.003.
   PubMed Web of Science ®Google Scholar
• Yang K, Han X. Lipidomics: techniques, applications, and outcomes related to biomedical sciences. Trends Biochem Sci. 2016;41(11):954–69. doi: 10.1016/j.tibs.2016.08.010.
   PubMed Web of Science ®Google Scholar
• Snaebjornsson MT, Janaki-Raman S, Schulze A. Greasing the wheels of the cancer machine: the role of lipid metabolism in cancer. Cell Metab. 2020;31(1):62–76. doi: 10.1016/j.cmet.2019.11.010.
   PubMed Web of Science ®Google Scholar
• Costello E. A metabolomics-based biomarker signature discriminates pancreatic cancer from chronic pancreatitis. Gut. 2018;67(1):2–3. doi: 10.1136/gutjnl-2016-313665.
   PubMed Web of Science ®Google Scholar
• Perrotti F, Rosa C, Cicalini I, Sacchetta P, Del Boccio P, Genovesi D, Pieragostino D. Advances in lipidomics for cancer biomarkers discovery. Int J Mol Sci. 2016;17(12):1992. doi: 10.3390/ijms17121992.
   PubMed Web of Science ®Google Scholar
• Han X. Lipidomics for studying metabolism. Nat Rev Endocrinol. 2016;12(11):668–79. doi: 10.1038/nrendo.2016.98.
   PubMed Web of Science ®Google Scholar
• Hu C, van der Heijden R, Wang M, van der Greef J, Hankemeier T, Xu G. Analytical strategies in lipidomics and applications in disease biomarker discovery. J Chromatogr B Analyt Technol Biomed Life Sci. 2009;877(26):2836–46. doi: 10.1016/j.jchromb.2009.01.038.
   PubMed Web of Science ®Google Scholar
• Mir SA, Rajagopalan P, Jain AP, Khan AA, Datta KK, Mohan SV, Lateef SS, Sahasrabuddhe N, Somani BL, Keshava Prasad TS, et al. LC-MS-based serum metabolomic analysis reveals dysregulation of phosphatidylcholines in esophageal squamous cell carcinoma. J Proteomics. 2015;127(Pt A):96–102. doi: 10.1016/j.jprot.2015.05.013.
   PubMedGoogle Scholar
• Ma W, Wang S, Zhang T, Zhang EY, Zhou L, Hu C, Yu JJ, Xu G. Activation of choline kinase drives aberrant choline metabolism in esophageal squamous cell carcinomas. J Pharm Biomed Anal. 2018;155:148–56. doi: 10.1016/j.jpba.2018.03.062.
   PubMed Web of Science ®Google Scholar
• Rice TW, Ishwaran H, Ferguson MK, Blackstone EH, Goldstraw P. Cancer of the esophagus and esophagogastric junction: an eighth edition staging primer. J Thorac Oncol. 2017;12(1):36–42. doi: 10.1016/j.jtho.2016.10.016.
   PubMed Web of Science ®Google Scholar
• Long J, Zhang CJ, Zhu N, Du K, Yin YF, Tan X, Liao DF, Qin L. Lipid metabolism and carcinogenesis, cancer development. Am J Cancer Res. 2018;8(5):778–91.
   PubMed Web of Science ®Google Scholar
• Yan F, Zhao H, Zeng Y. Lipidomics: a promising cancer biomarker. Clin Transl Med. 2018;7(1):21. doi: 10.1186/s40169-018-0199-0.
   PubMedGoogle Scholar
• Mistry DA, French PW. Circulating phospholipids as biomarkers of breast cancer: a review. Breast Cancer. 2016;10:191–6. doi: 10.4137/BCBCR.S40693.
   PubMedGoogle Scholar
• Ridgway ND. The role of phosphatidylcholine and choline metabolites to cell proliferation and survival. Crit Rev Biochem Mol Biol. 2013;48(1):20–38. doi: 10.3109/10409238.2012.735643.
   PubMed Web of Science ®Google Scholar
• Cífková E, Holčapek M, Lísa M, Vrána D, Gatěk J, Melichar B. Determination of lipidomic differences between human breast cancer and surrounding normal tissues using HILIC-HPLC/ESI-MS and multivariate data analysis. Anal Bioanal Chem. 2015;407(3):991–1002. doi: 10.1007/s00216-014-8272-z.
   PubMed Web of Science ®Google Scholar
• Ide Y, Waki M, Hayasaka T, Nishio T, Morita Y, Tanaka H, Sasaki T, Koizumi K, Matsunuma R, Hosokawa Y, et al. Human breast cancer tissues contain abundant phosphatidylcholine(36 : 1) with high stearoyl-CoA desaturase-1 expression. PLOS One. 2013;8(4):e61204. doi: 10.1371/journal.pone.0061204.
   PubMed Web of Science ®Google Scholar
• Cheng M, Bhujwalla ZM, Glunde K. Targeting phospholipid metabolism in cancer. Front Oncol. 2016;6:266. doi: 10.3389/fonc.2016.00266.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Liu Y, Li L, Wei J, Xiong S, Zhao Z. High resolution mass spectrometry coupled with multivariate data analysis revealing plasma lipidomic alteration in ovarian cancer in Asian women. Talanta. 2016;150:88–96. doi:10.1016/j.talanta.2015.12.021.
   PubMed Web of Science ®Google Scholar
• Chen X, Chen H, Dai M, Ai J, Li Y, Mahon B, Dai S, Deng Y. Plasma lipidomics profiling identified lipid biomarkers in distinguishing early-stage breast cancer from benign lesions. Oncotarget. 2016;7(24):36622–31. doi:10.18632/oncotarget.9124.
   PubMedGoogle Scholar
• Saito K, Arai E, Maekawa K, Ishikawa M, Fujimoto H, Taguchi R, Matsumoto K, Kanai Y, Saito Y. Lipidomic signatures and associated transcriptomic profiles of clear cell renal cell carcinoma. Sci Rep. 2016;6(1):28932. doi:10.1038/srep28932.
   PubMedGoogle Scholar
• Zhu ZJ, Qi Z, Zhang J, Xue WH, Li LF, Shen ZB, Li ZY, Yuan YL, Wang WB, Zhao J. Untargeted metabolomics analysis of esophageal squamous cell carcinoma discovers dysregulated metabolic pathways and potential diagnostic biomarkers. J Cancer. 2020;11(13):3944–54. doi: 10.7150/jca.41733.
   PubMed Web of Science ®Google Scholar
• Chen Y, Ma Z, Shen X, Li L, Zhong J, Min LS, Xu L, Li H, Zhang J, Dai L. Serum lipidomics profiling to identify biomarkers for non-small cell lung cancer. Biomed Res Int. 2018;7:5276240. doi: 10.1155/2018/5276240.
   Google Scholar
• Lu Y, Chen J, Huang C, Li N, Zou L, Chia SE, Chen S, Yu K, Ling Q, Cheng Q, et al. Comparison of hepatic and serum lipid signatures in hepatocellular carcinoma patients leads to the discovery of diagnostic and prognostic biomarkers. Oncotarget. 2017;9(4):5032–43. doi: 10.18632/oncotarget.23494.
   PubMedGoogle Scholar
• Lee GB, Lee JC, Moon MH. Plasma lipid profile comparison of five different cancers by nanoflow ultrahigh performance liquid chromatography-tandem mass spectrometry. Anal Chim Acta. 2019;1063:117–26. doi: 10.1016/j.aca.2019.02.021.
   PubMed Web of Science ®Google Scholar
• Cheng F, Wen Z, Feng X, Wang X, Chen Y. A serum lipidomic strategy revealed potential lipid biomarkers for early-stage cervical cancer. Life Sci. 2020;260:118489. doi: 10.1016/j.lfs.2020.118489.
   PubMed Web of Science ®Google Scholar
• Nagata S, Suzuki J, Segawa K, Fujii T. Exposure of phosphatidylserine on the cell surface. Cell Death Differ. 2016;23(6):952–61. doi: 10.1038/cdd.2016.7.
   PubMed Web of Science ®Google Scholar
• Luo X, Cheng C, Tan Z, Li N, Tang M, Yang L, Cao Y. Emerging roles of lipid metabolism in cancer metastasis. Mol Cancer. 2017;16(1):76. doi: 10.1186/s12943-017-0646-3.
   PubMed Web of Science ®Google Scholar
• Jones SF, Infante JR. Molecular pathways: fatty acid synthase. Clin Cancer Res. 2015;21(24):5434–8. doi: 10.1158/1078-0432.CCR-15-0126.
   PubMed Web of Science ®Google Scholar
• Jesionowska A, Cecerska-Heryc E, Matoszka N, Dolegowska B. Lysophosphatidic acid signaling in ovarian cancer. J Recept Signal Transduct Res. 2015;35(6):578–84. doi: 10.3109/10799893.2015.1026444.
   PubMed Web of Science ®Google Scholar
• Röhrig F, Schulze A. The multifaceted roles of fatty acid synthesis in cancer. Nat Rev Cancer. 2016;16(11):732–49. doi: 10.1038/nrc.2016.89.
   PubMed Web of Science ®Google Scholar
• Qu Q, Zeng F, Liu X, Wang QJ, Deng F. Fatty acid oxidation and carnitine palmitoyltransferase I: emerging therapeutic targets in cancer. Cell Death Dis. 2016;7(5):e2226. doi: 10.1038/cddis.2016.132.
   PubMedGoogle Scholar
• Klupczynska A, Plewa S, Kasprzyk M, Dyszkiewicz W, Kokot ZJ, Matysiak J. Serum lipidome screening in patients with stage I non-small cell lung cancer. Clin Exp Med. 2019;19(4):505–13. doi: 10.1007/s10238-019-00566-7
   PubMed Web of Science ®Google Scholar